Aurobindo Pharma Ltd has received the final approval from the US Food and Drug Administration (US FDA) for Donepezil Hydrochloride tablets. Donepezil hydrochloride tablet is the generic equivalent to Aricept tablets Eisai Medical Research Inc, the Hyderabad-based company said in a release.
They are indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer's type and fall under the Central Nervous System therapeutic segment. The product had a market size of approximately $2.5 billion for the 12 months ended September 2010 and the product would be launched soon, the company added.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.